And the world goes forward as BB fiddles! Dubli
Post# of 9122
Dublin, Ireland, 12 January 2017 ... A joint study conducted by Dublin-based molecular diagnostics manufacturer HiberGene and the National Maternity Hospital (NMH), Dublin has found HiberGene’s Group B Streptococcus (GBS) to be an accurate and rapid alternative to testing with the current gold standard microbiological culture method.
The results from the study showed that HiberGene’s GBS Test was able to accurately detect the presence of GBS in pregnant women, and found that 19 percent of those tested carried GBS. The blinded study involved sampling and testing of 400 pregnant women, with microbiological testing performed at NMH and molecular testing performed independently at HiberGene’s R&D facility.
The gold standard technique for identification of GBS takes 48 hours to run in a dedicated microbiology lab, and is not suitable for real time detection of infection during childbirth. HiberGene’s molecular test, in contrast, returns a result in approximately one hour and can be performed with minimal laboratory facilities.